Beta Bionics, Inc. · NASDAQ:BBNX
Hopman Mark sold 370 Beta Bionics, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Hopman Mark (Chief Commercial Officer) sold 370 Beta Bionics, Inc. shares at US$16.90 for US$6,253 under a trading plan, leaving 54,143 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 370 shares
- Price
- US$16.90
- Value
- US$6,253
- Holding after
- 54,143 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Sale | 370 | US$16.90 | 54,143 | Direct |
Source
Download original · View original at SEC
Related
- Beta Bionics, Inc.
- Hopman Mark
- Beta Bionics, Inc. shareholders
- Form 4 · Hopman Mark · Nov 18, 2026
- Form 4 · Hopman Mark · Oct 28, 2026
- Form 4 · Hopman Mark · Oct 16, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026
- Schedule 13G/A · Divisadero Street Capital Management, LP · Nov 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 16, 2026
- Form 4 · Feider Stephen · Nov 13, 2026
- Form 4 · Feider Stephen · Nov 12, 2026
- Form 4 · Feider Stephen · Nov 9, 2026